< 1 minute read
Nov. 26, 2021

Onametostat: A Selective Orally Pseudo-Irreversible PRMT5 Inhibitor

JNJ-64619178

pseudo-irreversible methyltransferase inh. oral, phase I, cancer from adenosine derivative library + opt. Molecular Cancer Therapeutics Janssen R&D

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in